# A Study to Assess the Safety and Immunogenicity of a New Influenza Vaccine Candidate MVA-NP+M1 in Healthy Adults

> **NCT00942071** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 58 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** MVA-NP+M1
- **BIOLOGICAL:** MVA-NP+M1
- **BIOLOGICAL:** MVA-NP+M1

## Key facts

- **NCT ID:** NCT00942071
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2012-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00942071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00942071, "A Study to Assess the Safety and Immunogenicity of a New Influenza Vaccine Candidate MVA-NP+M1 in Healthy Adults". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00942071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*